New and updated reports from the Congressional Research Service include the following.
Tit-for-Tat Tariff Measures and U.S. Trade Policy, CRS Insight, July 11, 2018
Renewable Energy and Energy Efficiency Incentives: A Summary of Federal Programs, updated July 11, 2018
Military Transition Assistance Program (TAP): An Overview, CRS In Focus, updated July 12, 2018
Risk and Needs Assessment in the Federal Prison System, updated July 10, 2018
Senate Judiciary Committee Hearings for a Supreme Court Nominee: Overview, CRS Insight, July 12, 2018
Justice Anthony Kennedy: His Jurisprudence and the Future of the Court, July 11, 2018
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.